Last reviewed · How we verify
Post-operative Ondansetron anti-emesis
Post-operative Ondansetron anti-emesis is a Small molecule drug developed by James Cook University Hospital. It is currently in Phase 1 development.
At a glance
| Generic name | Post-operative Ondansetron anti-emesis |
|---|---|
| Sponsor | James Cook University Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Muscle weakness upper limb [left]
- Numbness in left arm
- Paresthesia [left]
- Hematoma
- Muscle weakness upper limb [right]
- Numbness in right arm
- Pain in extremity
- Paresthesia [right]
Key clinical trials
- Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) (NA)
- Ondansetron vs. Dexamethasone for Postoperative Nausea (PHASE4)
- Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron (PHASE4)
- Postoperative Vomiting in Children - Is Dextrose an Effective Prophylactic Anti-emetic? (NA)
- Simplified Algorithm for the Prevention of Postoperative Nausea and Vomiting in an Oncological Hospital (PHASE2)
- Trial- Dysphagia From ETT or GI Endoscopy (NA)
- Chewing Gum to Prevent Nausea and Vomiting After Caesarean Section Under Spinal Anaesthesia (NA)
- Enhanced Recovery After Cardiac Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Post-operative Ondansetron anti-emesis CI brief — competitive landscape report
- Post-operative Ondansetron anti-emesis updates RSS · CI watch RSS
- James Cook University Hospital portfolio CI
Frequently asked questions about Post-operative Ondansetron anti-emesis
What is Post-operative Ondansetron anti-emesis?
Post-operative Ondansetron anti-emesis is a Small molecule drug developed by James Cook University Hospital.
Who makes Post-operative Ondansetron anti-emesis?
Post-operative Ondansetron anti-emesis is developed by James Cook University Hospital (see full James Cook University Hospital pipeline at /company/james-cook-university-hospital).
What development phase is Post-operative Ondansetron anti-emesis in?
Post-operative Ondansetron anti-emesis is in Phase 1.
What are the side effects of Post-operative Ondansetron anti-emesis?
Common side effects of Post-operative Ondansetron anti-emesis include Muscle weakness upper limb [left], Numbness in left arm, Paresthesia [left], Hematoma, Muscle weakness upper limb [right], Numbness in right arm.